- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
According to our latest study, the global MRI Contrast Agents market size was valued at USD 1425 million in 2022 and is forecast to a readjusted size of USD 2089.1 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.
This report is a detailed and comprehensive analysis for global MRI Contrast Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global MRI Contrast Agents market size and forecasts, in consumption value ($ Million), sales quantity (Liter), and average selling prices (US$/mL), 2018-2029
Global MRI Contrast Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Liter), and average selling prices (US$/mL), 2018-2029
Global MRI Contrast Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Liter), and average selling prices (US$/mL), 2018-2029
Global MRI Contrast Agents market shares of main players, shipments in revenue ($ Million), sales quantity (Liter), and ASP (US$/mL), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for MRI Contrast Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global MRI Contrast Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare and BeiLu Pharma and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
MRI Contrast Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gadobutrol
Gadoterate Meglumine
Gadobenate Dimeglumine
Gadopentetate Dimeglumine
Gadoteridol
Gadodiamine
Others
Market segment by Application
Hospitals
Clinics
Major players covered
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe MRI Contrast Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of MRI Contrast Agents, with price, sales, revenue and global market share of MRI Contrast Agents from 2018 to 2023.
Chapter 3, the MRI Contrast Agents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the MRI Contrast Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and MRI Contrast Agents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of MRI Contrast Agents.
Chapter 14 and 15, to describe MRI Contrast Agents sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of MRI Contrast Agents
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global MRI Contrast Agents Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Gadobutrol
1.3.3 Gadoterate Meglumine
1.3.4 Gadobenate Dimeglumine
1.3.5 Gadopentetate Dimeglumine
1.3.6 Gadoteridol
1.3.7 Gadodiamine
1.3.8 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global MRI Contrast Agents Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.5 Global MRI Contrast Agents Market Size & Forecast
1.5.1 Global MRI Contrast Agents Consumption Value (2018 & 2022 & 2029)
1.5.2 Global MRI Contrast Agents Sales Quantity (2018-2029)
1.5.3 Global MRI Contrast Agents Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer MRI Contrast Agents Product and Services
2.1.4 Bayer MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments/Updates
2.2 Guerbet Group
2.2.1 Guerbet Group Details
2.2.2 Guerbet Group Major Business
2.2.3 Guerbet Group MRI Contrast Agents Product and Services
2.2.4 Guerbet Group MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Guerbet Group Recent Developments/Updates
2.3 Bracco Imaging
2.3.1 Bracco Imaging Details
2.3.2 Bracco Imaging Major Business
2.3.3 Bracco Imaging MRI Contrast Agents Product and Services
2.3.4 Bracco Imaging MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bracco Imaging Recent Developments/Updates
2.4 GE Healthcare
2.4.1 GE Healthcare Details
2.4.2 GE Healthcare Major Business
2.4.3 GE Healthcare MRI Contrast Agents Product and Services
2.4.4 GE Healthcare MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GE Healthcare Recent Developments/Updates
2.5 BeiLu Pharma
2.5.1 BeiLu Pharma Details
2.5.2 BeiLu Pharma Major Business
2.5.3 BeiLu Pharma MRI Contrast Agents Product and Services
2.5.4 BeiLu Pharma MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BeiLu Pharma Recent Developments/Updates
2.6 Hengrui Medicine
2.6.1 Hengrui Medicine Details
2.6.2 Hengrui Medicine Major Business
2.6.3 Hengrui Medicine MRI Contrast Agents Product and Services
2.6.4 Hengrui Medicine MRI Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hengrui Medicine Recent Developments/Updates
3 Competitive Environment: MRI Contrast Agents by Manufacturer
3.1 Global MRI Contrast Agents Sales Quantity by Manufacturer (2018-2023)
3.2 Global MRI Contrast Agents Revenue by Manufacturer (2018-2023)
3.3 Global MRI Contrast Agents Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of MRI Contrast Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 MRI Contrast Agents Manufacturer Market Share in 2022
3.4.2 Top 6 MRI Contrast Agents Manufacturer Market Share in 2022
3.5 MRI Contrast Agents Market: Overall Company Footprint Analysis
3.5.1 MRI Contrast Agents Market: Region Footprint
3.5.2 MRI Contrast Agents Market: Company Product Type Footprint
3.5.3 MRI Contrast Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global MRI Contrast Agents Market Size by Region
4.1.1 Global MRI Contrast Agents Sales Quantity by Region (2018-2029)
4.1.2 Global MRI Contrast Agents Consumption Value by Region (2018-2029)
4.1.3 Global MRI Contrast Agents Average Price by Region (2018-2029)
4.2 North America MRI Contrast Agents Consumption Value (2018-2029)
4.3 Europe MRI Contrast Agents Consumption Value (2018-2029)
4.4 Asia-Pacific MRI Contrast Agents Consumption Value (2018-2029)
4.5 South America MRI Contrast Agents Consumption Value (2018-2029)
4.6 Middle East and Africa MRI Contrast Agents Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global MRI Contrast Agents Sales Quantity by Type (2018-2029)
5.2 Global MRI Contrast Agents Consumption Value by Type (2018-2029)
5.3 Global MRI Contrast Agents Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global MRI Contrast Agents Sales Quantity by Application (2018-2029)
6.2 Global MRI Contrast Agents Consumption Value by Application (2018-2029)
6.3 Global MRI Contrast Agents Average Price by Application (2018-2029)
7 North America
7.1 North America MRI Contrast Agents Sales Quantity by Type (2018-2029)
7.2 North America MRI Contrast Agents Sales Quantity by Application (2018-2029)
7.3 North America MRI Contrast Agents Market Size by Country
7.3.1 North America MRI Contrast Agents Sales Quantity by Country (2018-2029)
7.3.2 North America MRI Contrast Agents Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe MRI Contrast Agents Sales Quantity by Type (2018-2029)
8.2 Europe MRI Contrast Agents Sales Quantity by Application (2018-2029)
8.3 Europe MRI Contrast Agents Market Size by Country
8.3.1 Europe MRI Contrast Agents Sales Quantity by Country (2018-2029)
8.3.2 Europe MRI Contrast Agents Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific MRI Contrast Agents Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific MRI Contrast Agents Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific MRI Contrast Agents Market Size by Region
9.3.1 Asia-Pacific MRI Contrast Agents Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific MRI Contrast Agents Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America MRI Contrast Agents Sales Quantity by Type (2018-2029)
10.2 South America MRI Contrast Agents Sales Quantity by Application (2018-2029)
10.3 South America MRI Contrast Agents Market Size by Country
10.3.1 South America MRI Contrast Agents Sales Quantity by Country (2018-2029)
10.3.2 South America MRI Contrast Agents Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa MRI Contrast Agents Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa MRI Contrast Agents Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa MRI Contrast Agents Market Size by Country
11.3.1 Middle East & Africa MRI Contrast Agents Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa MRI Contrast Agents Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 MRI Contrast Agents Market Drivers
12.2 MRI Contrast Agents Market Restraints
12.3 MRI Contrast Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of MRI Contrast Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of MRI Contrast Agents
13.3 MRI Contrast Agents Production Process
13.4 MRI Contrast Agents Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 MRI Contrast Agents Typical Distributors
14.3 MRI Contrast Agents Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global MRI Contrast Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global MRI Contrast Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer MRI Contrast Agents Product and Services
Table 6. Bayer MRI Contrast Agents Sales Quantity (Liter), Average Price (US$/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Recent Developments/Updates
Table 8. Guerbet Group Basic Information, Manufacturing Base and Competitors
Table 9. Guerbet Group Major Business
Table 10. Guerbet Group MRI Contrast Agents Product and Services
Table 11. Guerbet Group MRI Contrast Agents Sales Quantity (Liter), Average Price (US$/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Guerbet Group Recent Developments/Updates
Table 13. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 14. Bracco Imaging Major Business
Table 15. Bracco Imaging MRI Contrast Agents Product and Services
Table 16. Bracco Imaging MRI Contrast Agents Sales Quantity (Liter), Average Price (US$/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bracco Imaging Recent Developments/Updates
Table 18. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 19. GE Healthcare Major Business
Table 20. GE Healthcare MRI Contrast Agents Product and Services
Table 21. GE Healthcare MRI Contrast Agents Sales Quantity (Liter), Average Price (US$/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GE Healthcare Recent Developments/Updates
Table 23. BeiLu Pharma Basic Information, Manufacturing Base and Competitors
Table 24. BeiLu Pharma Major Business
Table 25. BeiLu Pharma MRI Contrast Agents Product and Services
Table 26. BeiLu Pharma MRI Contrast Agents Sales Quantity (Liter), Average Price (US$/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. BeiLu Pharma Recent Developments/Updates
Table 28. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 29. Hengrui Medicine Major Business
Table 30. Hengrui Medicine MRI Contrast Agents Product and Services
Table 31. Hengrui Medicine MRI Contrast Agents Sales Quantity (Liter), Average Price (US$/mL), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hengrui Medicine Recent Developments/Updates
Table 33. Global MRI Contrast Agents Sales Quantity by Manufacturer (2018-2023) & (Liter)
Table 34. Global MRI Contrast Agents Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global MRI Contrast Agents Average Price by Manufacturer (2018-2023) & (US$/mL)
Table 36. Market Position of Manufacturers in MRI Contrast Agents, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and MRI Contrast Agents Production Site of Key Manufacturer
Table 38. MRI Contrast Agents Market: Company Product Type Footprint
Table 39. MRI Contrast Agents Market: Company Product Application Footprint
Table 40. MRI Contrast Agents New Market Entrants and Barriers to Market Entry
Table 41. MRI Contrast Agents Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global MRI Contrast Agents Sales Quantity by Region (2018-2023) & (Liter)
Table 43. Global MRI Contrast Agents Sales Quantity by Region (2024-2029) & (Liter)
Table 44. Global MRI Contrast Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global MRI Contrast Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global MRI Contrast Agents Average Price by Region (2018-2023) & (US$/mL)
Table 47. Global MRI Contrast Agents Average Price by Region (2024-2029) & (US$/mL)
Table 48. Global MRI Contrast Agents Sales Quantity by Type (2018-2023) & (Liter)
Table 49. Global MRI Contrast Agents Sales Quantity by Type (2024-2029) & (Liter)
Table 50. Global MRI Contrast Agents Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global MRI Contrast Agents Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global MRI Contrast Agents Average Price by Type (2018-2023) & (US$/mL)
Table 53. Global MRI Contrast Agents Average Price by Type (2024-2029) & (US$/mL)
Table 54. Global MRI Contrast Agents Sales Quantity by Application (2018-2023) & (Liter)
Table 55. Global MRI Contrast Agents Sales Quantity by Application (2024-2029) & (Liter)
Table 56. Global MRI Contrast Agents Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global MRI Contrast Agents Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global MRI Contrast Agents Average Price by Application (2018-2023) & (US$/mL)
Table 59. Global MRI Contrast Agents Average Price by Application (2024-2029) & (US$/mL)
Table 60. North America MRI Contrast Agents Sales Quantity by Type (2018-2023) & (Liter)
Table 61. North America MRI Contrast Agents Sales Quantity by Type (2024-2029) & (Liter)
Table 62. North America MRI Contrast Agents Sales Quantity by Application (2018-2023) & (Liter)
Table 63. North America MRI Contrast Agents Sales Quantity by Application (2024-2029) & (Liter)
Table 64. North America MRI Contrast Agents Sales Quantity by Country (2018-2023) & (Liter)
Table 65. North America MRI Contrast Agents Sales Quantity by Country (2024-2029) & (Liter)
Table 66. North America MRI Contrast Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America MRI Contrast Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe MRI Contrast Agents Sales Quantity by Type (2018-2023) & (Liter)
Table 69. Europe MRI Contrast Agents Sales Quantity by Type (2024-2029) & (Liter)
Table 70. Europe MRI Contrast Agents Sales Quantity by Application (2018-2023) & (Liter)
Table 71. Europe MRI Contrast Agents Sales Quantity by Application (2024-2029) & (Liter)
Table 72. Europe MRI Contrast Agents Sales Quantity by Country (2018-2023) & (Liter)
Table 73. Europe MRI Contrast Agents Sales Quantity by Country (2024-2029) & (Liter)
Table 74. Europe MRI Contrast Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe MRI Contrast Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific MRI Contrast Agents Sales Quantity by Type (2018-2023) & (Liter)
Table 77. Asia-Pacific MRI Contrast Agents Sales Quantity by Type (2024-2029) & (Liter)
Table 78. Asia-Pacific MRI Contrast Agents Sales Quantity by Application (2018-2023) & (Liter)
Table 79. Asia-Pacific MRI Contrast Agents Sales Quantity by Application (2024-2029) & (Liter)
Table 80. Asia-Pacific MRI Contrast Agents Sales Quantity by Region (2018-2023) & (Liter)
Table 81. Asia-Pacific MRI Contrast Agents Sales Quantity by Region (2024-2029) & (Liter)
Table 82. Asia-Pacific MRI Contrast Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific MRI Contrast Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America MRI Contrast Agents Sales Quantity by Type (2018-2023) & (Liter)
Table 85. South America MRI Contrast Agents Sales Quantity by Type (2024-2029) & (Liter)
Table 86. South America MRI Contrast Agents Sales Quantity by Application (2018-2023) & (Liter)
Table 87. South America MRI Contrast Agents Sales Quantity by Application (2024-2029) & (Liter)
Table 88. South America MRI Contrast Agents Sales Quantity by Country (2018-2023) & (Liter)
Table 89. South America MRI Contrast Agents Sales Quantity by Country (2024-2029) & (Liter)
Table 90. South America MRI Contrast Agents Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America MRI Contrast Agents Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa MRI Contrast Agents Sales Quantity by Type (2018-2023) & (Liter)
Table 93. Middle East & Africa MRI Contrast Agents Sales Quantity by Type (2024-2029) & (Liter)
Table 94. Middle East & Africa MRI Contrast Agents Sales Quantity by Application (2018-2023) & (Liter)
Table 95. Middle East & Africa MRI Contrast Agents Sales Quantity by Application (2024-2029) & (Liter)
Table 96. Middle East & Africa MRI Contrast Agents Sales Quantity by Region (2018-2023) & (Liter)
Table 97. Middle East & Africa MRI Contrast Agents Sales Quantity by Region (2024-2029) & (Liter)
Table 98. Middle East & Africa MRI Contrast Agents Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa MRI Contrast Agents Consumption Value by Region (2024-2029) & (USD Million)
Table 100. MRI Contrast Agents Raw Material
Table 101. Key Manufacturers of MRI Contrast Agents Raw Materials
Table 102. MRI Contrast Agents Typical Distributors
Table 103. MRI Contrast Agents Typical Customers
List of Figures
Figure 1. MRI Contrast Agents Picture
Figure 2. Global MRI Contrast Agents Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global MRI Contrast Agents Consumption Value Market Share by Type in 2022
Figure 4. Gadobutrol Examples
Figure 5. Gadoterate Meglumine Examples
Figure 6. Gadobenate Dimeglumine Examples
Figure 7. Gadopentetate Dimeglumine Examples
Figure 8. Gadoteridol Examples
Figure 9. Gadodiamine Examples
Figure 10. Others Examples
Figure 11. Global MRI Contrast Agents Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 12. Global MRI Contrast Agents Consumption Value Market Share by Application in 2022
Figure 13. Hospitals Examples
Figure 14. Clinics Examples
Figure 15. Global MRI Contrast Agents Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global MRI Contrast Agents Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global MRI Contrast Agents Sales Quantity (2018-2029) & (Liter)
Figure 18. Global MRI Contrast Agents Average Price (2018-2029) & (US$/mL)
Figure 19. Global MRI Contrast Agents Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global MRI Contrast Agents Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of MRI Contrast Agents by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 MRI Contrast Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 MRI Contrast Agents Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global MRI Contrast Agents Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global MRI Contrast Agents Consumption Value Market Share by Region (2018-2029)
Figure 26. North America MRI Contrast Agents Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe MRI Contrast Agents Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific MRI Contrast Agents Consumption Value (2018-2029) & (USD Million)
Figure 29. South America MRI Contrast Agents Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa MRI Contrast Agents Consumption Value (2018-2029) & (USD Million)
Figure 31. Global MRI Contrast Agents Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global MRI Contrast Agents Consumption Value Market Share by Type (2018-2029)
Figure 33. Global MRI Contrast Agents Average Price by Type (2018-2029) & (US$/mL)
Figure 34. Global MRI Contrast Agents Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global MRI Contrast Agents Consumption Value Market Share by Application (2018-2029)
Figure 36. Global MRI Contrast Agents Average Price by Application (2018-2029) & (US$/mL)
Figure 37. North America MRI Contrast Agents Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America MRI Contrast Agents Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America MRI Contrast Agents Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America MRI Contrast Agents Consumption Value Market Share by Country (2018-2029)
Figure 41. United States MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe MRI Contrast Agents Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe MRI Contrast Agents Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe MRI Contrast Agents Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe MRI Contrast Agents Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific MRI Contrast Agents Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific MRI Contrast Agents Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific MRI Contrast Agents Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific MRI Contrast Agents Consumption Value Market Share by Region (2018-2029)
Figure 57. China MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America MRI Contrast Agents Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America MRI Contrast Agents Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America MRI Contrast Agents Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America MRI Contrast Agents Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa MRI Contrast Agents Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa MRI Contrast Agents Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa MRI Contrast Agents Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa MRI Contrast Agents Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa MRI Contrast Agents Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. MRI Contrast Agents Market Drivers
Figure 78. MRI Contrast Agents Market Restraints
Figure 79. MRI Contrast Agents Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of MRI Contrast Agents in 2022
Figure 82. Manufacturing Process Analysis of MRI Contrast Agents
Figure 83. MRI Contrast Agents Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
